163 related articles for article (PubMed ID: 11509961)
1. A novel system for mitigation of ectopic transgene expression induced by adenoviral vectors.
Reynolds PN; Holmes MD; Adachi Y; Kaliberova L; Curiel DT
Gene Ther; 2001 Aug; 8(16):1271-5. PubMed ID: 11509961
[TBL] [Abstract][Full Text] [Related]
2. Further reduction in adenovirus vector-mediated liver transduction without largely affecting transgene expression in target organ by exploiting microrna-mediated regulation and the Cre-loxP recombination system.
Bennett D; Sakurai F; Shimizu K; Matsui H; Tomita K; Suzuki T; Katayama K; Kawabata K; Mizuguchi H
Mol Pharm; 2012 Dec; 9(12):3452-63. PubMed ID: 23127182
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
4. Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory system.
Koch PE; Guo ZS; Kagawa S; Gu J; Roth JA; Fang B
Mol Ther; 2001 Mar; 3(3):278-83. PubMed ID: 11273768
[TBL] [Abstract][Full Text] [Related]
5. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo.
Steinwaerder DS; Lieber A
Gene Ther; 2000 Apr; 7(7):556-67. PubMed ID: 10819570
[TBL] [Abstract][Full Text] [Related]
6. Transgenic mouse for conditional, tissue-specific Cox-2 overexpression.
Kamei K; Ishikawa TO; Herschman HR
Genesis; 2006 Apr; 44(4):177-82. PubMed ID: 16604526
[TBL] [Abstract][Full Text] [Related]
7. Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.
Rivera AA; Wang M; Suzuki K; Uil TG; Krasnykh V; Curiel DT; Nettelbeck DM
Virology; 2004 Mar; 320(1):121-34. PubMed ID: 15003868
[TBL] [Abstract][Full Text] [Related]
8. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
[TBL] [Abstract][Full Text] [Related]
9. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
[TBL] [Abstract][Full Text] [Related]
10. Efficient in vitro and in vivo excision of floxed sequences with a high-capacity adenoviral vector expressing Cre recombinase.
Badorf M; Edenhofer F; Dries V; Kochanek S; Schiedner G
Genesis; 2002 Jul; 33(3):119-24. PubMed ID: 12124944
[TBL] [Abstract][Full Text] [Related]
11. Targeted gene therapy toward astrocytoma using a Cre/loxP-based adenovirus system.
Maeda M; Namikawa K; Kobayashi I; Ohba N; Takahara Y; Kadono C; Tanaka A; Kiyama H
Brain Res; 2006 Apr; 1081(1):34-43. PubMed ID: 16529724
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy progress and prospects: adenoviral vectors.
St George JA
Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122
[TBL] [Abstract][Full Text] [Related]
13. Neuron-restrictive silencer elements mediate neuron specificity of adenoviral gene expression.
Millecamps S; Kiefer H; Navarro V; Geoffroy MC; Robert JJ; Finiels F; Mallet J; Barkats M
Nat Biotechnol; 1999 Sep; 17(9):865-9. PubMed ID: 10471926
[TBL] [Abstract][Full Text] [Related]
14. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
Van Linthout S; Lusky M; Collen D; De Geest B
Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
[TBL] [Abstract][Full Text] [Related]
15. Cre-loxP system as a versatile tool for conferring increased levels of tissue-specific gene expression from a weak promoter.
Nakamura S; Watanabe S; Ohtsuka M; Maehara T; Ishihara M; Yokomine T; Sato M
Mol Reprod Dev; 2008 Jun; 75(6):1085-93. PubMed ID: 18163444
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers.
Yamamoto M; Alemany R; Adachi Y; Grizzle WE; Curiel DT
Mol Ther; 2001 Mar; 3(3):385-94. PubMed ID: 11273781
[TBL] [Abstract][Full Text] [Related]
17. Adenoviral vectors for liver-directed gene therapy.
Connelly S
Curr Opin Mol Ther; 1999 Oct; 1(5):565-72. PubMed ID: 11249663
[TBL] [Abstract][Full Text] [Related]
18. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo.
Reynolds PN; Zinn KR; Gavrilyuk VD; Balyasnikova IV; Rogers BE; Buchsbaum DJ; Wang MH; Miletich DJ; Grizzle WE; Douglas JT; Danilov SM; Curiel DT
Mol Ther; 2000 Dec; 2(6):562-78. PubMed ID: 11124057
[TBL] [Abstract][Full Text] [Related]
19. In vivo high-efficiency transcoronary gene delivery and Cre-LoxP gene switching in the adult mouse heart.
Iwatate M; Gu Y; Dieterle T; Iwanaga Y; Peterson KL; Hoshijima M; Chien KR; Ross J
Gene Ther; 2003 Oct; 10(21):1814-20. PubMed ID: 12960971
[TBL] [Abstract][Full Text] [Related]
20. Increased protein expression from adenoviral shuttle plasmids and vectors by insertion of a small chimeric intron sequence.
Hermening S; Kügler S; Bähr M; Isenmann S
J Virol Methods; 2004 Dec; 122(1):73-7. PubMed ID: 15488623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
